This inventor holds 1 USPTO granted patent. Top assignee: Universitë De Bordeaux. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Jerome Rambert: Innovator in Peptide Research
Introduction
Jerome Rambert is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of peptide research, particularly in the development of compounds that can bind to CD23. His work has implications for treating various inflammatory conditions.
Latest Patents
Jerome Rambert holds a patent for "Peptides and peptidomimetics binding to CD23." This invention describes compounds that comprise new and useful peptides and peptidomimetics capable of reducing inflammatory responses associated with autoimmune diseases, chronic inflammatory diseases, allergies, and other inflammatory conditions mediated by the mammalian immune system. The patent details a CD23-binding peptide with a specific amino-acid sequence that includes various combinations of amino acids such as Phe, His, Ala, Glu, and others.
Career Highlights
Jerome Rambert is affiliated with the Université de Bordeaux, where he conducts his research and development work. His innovative approach to peptide design has positioned him as a key figure in the scientific community focused on immunology and inflammatory diseases.
Collaborations
Jerome has collaborated with esteemed colleagues such as Mohammad Djavad Mossalayi and Philippe Vincendeau. These partnerships have enhanced the scope and impact of his research.
Conclusion
Jerome Rambert's contributions to peptide research and his innovative patent demonstrate his commitment to advancing medical science. His work holds promise for improving treatments for various inflammatory conditions.